Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 24.27
+0.86 (3.67%)
At close: Mar 6, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 2.63 billion as of March 6, 2026. Its market cap has increased by 35.59% in one year.
Market Cap
2.63B
Enterprise Value
1.84B
Revenue
196.21M
Ranking
n/a
PE Ratio
50.56
Stock Price
24.27
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 2.63B, a decrease of -56.11%. That is a compound annual growth rate of -18.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.63B | 11.48% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fushilai Pharmaceutical | 2.94B |
| Landfar Bio-medicine | 2.91B |
| Jiangsu Sihuan Bioengineering | 2.89B |
| Jilin Jian Yisheng Pharmaceutical | 2.78B |
| Shandong Sito Bio-technology | 2.77B |
| Shanghai Universal Biotech | 2.73B |
| Zhejiang East Asia Pharmaceutical | 2.58B |
| Jiangsu CoWin Biotech | 2.54B |